常德市微创血肿引流术治疗高血压性脑出血开展现状及其疗效分析

Current Situation and Analysis of the Efficacy of Minimal-invasive Hematoma Drainage for the Treatment of Hypertensive Cerebral Hemorrhage in Changde City

【目的】了解常德市微创血肿引流术治疗高血压性脑出血开展现状并对其疗效进行评价。【方法】提取常德市多中心脑卒中登记数据库5338例患者中行微创血肿引流术的高血压性脑出血患者398例（观察组），抽取同期行内科保守治疗高血压性脑出血患者253例（对照组）；回顾性分析两组高血压性脑出血患者的病死率、神经功能康复等情况。【结果】观察组患者病死率及并发症发生率显著低于对照组（P〈O．05），而血肿增大致死比例显著高于对照组（Pd0．05）。观察组治疗后14d、28d的NHISS评分明显低于对照组（Pd0．05）。【结论】微创血肿引流术能有效的减少高血压性脑出血患者的病死率，有助于其神经功能的后期康复。

[Objective]To understand the current situation of minimal-invasive hematoma drainage for the treatment of hypertensive cerebral hemorrhage in Changde city and to evaluate its efficacy. [Methods] Totally 398 patients with hypertensive cerebral hemorrhage undergoing minimal-invasive hematoma drainage among 5338 patients in multicenter stroke registration database of Changde city were chosen as the observation group. Other 253 patients with hypertensive cerebral hemorrhage receiving internal medical conservation treatment at the same time were chosen as the control group. The mortality and nerve function recovery of patients with hy- pertensive cerebral hemorrhage in two groups were analyzed retrospectively. [Results] There were significant differences in the mortality, complications and fatality rate of hematoma enlargement between two groups（ P 〈0.05）. NHISS score at 14d and 28d after treatment in the observation group was obviously lower than that in the control group（ P 〈0.05）. [Conclusion] Minimal-invasive hematoma drainage can effectively reduce the mortality of patients with hypertensive cerebral hemorrhage, and is helpful for nerve function rehabilitation in later period.